🇩🇪 On February 11-12, EP PerMed – the European Partnership for Personalised Medicine hosted its Conference on “Personalised Medicine Research”, bringing together 250 international experts in Berlin to discuss the latest advances in personalised medicine.
🗣️ We are proud that Susana Ochoa (Fundació de Recerca Sant Joan de Déu) delivered an outstanding presentation on PERMEPSY’s work in the session “Clinical Trial Design for Personalised Medicine.”
Her talk highlighted how the PERMEPSY project leverages machine learning to enhance hasztag#MCT for psychosis treatment, contributing to the broader goal of advancing personalised psychological care.
👏 A fantastic opportunity to share our work and connect with fellow researchers shaping the future of personalised medicine!
🟢 How can machine learning enhance benefits from MCT for psychosis? 🟢
One of our members, Adrien Goncalves, presented at the 22nd Schizophrenia Days (Journées de la Schizophrénie – PositiveMinders). 🎤 Conference (in French): “When AI steps
2025-03-21
